These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29285374)

  • 1. Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report.
    Katano A; Yamashita H; Nakagawa K
    Mol Clin Oncol; 2017 Dec; 7(6):1061-1063. PubMed ID: 29285374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative solitary liver metastasis from esophageal squamous cell carcinoma achieving a clinical complete response to chemotherapy with cisplatin and 5-fluorouracil followed by stereotactic body radiotherapy: A case report.
    Fukuda S; Okajima K; Okada K; Fukuda K; Wakasa T; Tsujimoto T; Gakuhara A; Tomihara H; Ohta K; Kitani K; Hashimoto K; Ishikawa H; Hida JI; Yukawa M; Ohta Y; Inoue M
    Mol Clin Oncol; 2021 Jul; 15(1):130. PubMed ID: 34055345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature.
    Xu M; Huang H; Xiong Y; Peng B; Zhou Z; Wang D; Yang X
    Oncol Lett; 2014 Jul; 8(1):291-294. PubMed ID: 24959263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful definitive concurrent chemoradiotherapy in a patient with esophageal cancer and Child-Pugh B cirrhosis of the liver.
    Katano A; Yamashita H; Nakagawa K
    J Cancer Res Ther; 2019; 15(1):255-257. PubMed ID: 30880788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of liver metastasis from esophageal cancer treated with stereotactic body radiation therapy].
    Egawa T; Okubo Y; Kemmochi T; Mori T; Sato S; Nishiya S; Mihara K; Ito Y; Makino H; Nagashima A
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1850-2. PubMed ID: 24393943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.
    Cha YJ; Kim MS; Jang WI; Seo YS; Cho CK; Yoo HJ; Paik EK
    Radiat Oncol J; 2017 Jun; 35(2):172-179. PubMed ID: 28712274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nedaplatin-based chemotherapy regimens combined with concurrent radiotherapy as first-line treatment for stage II-III esophageal squamous cell carcinoma.
    Zhu H; Ge X; Lu Y; Zuo Y; Qin Q; Sun X; Yang M
    Oncol Lett; 2019 Jan; 17(1):594-602. PubMed ID: 30655806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report.
    Sakanaka K; Fujii K; Mizowaki T
    BMC Cancer; 2020 Jan; 20(1):21. PubMed ID: 31906910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report.
    Katano A; Yamashita H; Okuma K; Nakagawa K
    Oncol Lett; 2016 Jun; 11(6):3901-3903. PubMed ID: 27313714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
    Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
    Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases.
    Katano A; Yamashita H; Nakagawa K
    Mol Clin Oncol; 2017 Oct; 7(4):681-686. PubMed ID: 29046800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy as a bridge to transplantation and for recurrent disease in the transplanted liver of a patient with hepatocellular carcinoma.
    Mazloom A; Hezel AF; Katz AW
    Case Rep Oncol; 2014 Jan; 7(1):18-22. PubMed ID: 24575010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.